Michigan-based digital manufacturer, Extol, Inc., announces FDA registration for contract manufacturing of 3D printed medical devices. The FDA registration will allow Extol to expand its offerings for the life-sciences industry. It will immediately impact Extol’s capability to provide complete solutions for additive manufacturing of medical devices for the orthotics and prosthetics (O&P) market.
Extol has been awarded as a finalist for the Cool Parts Showcase by Additive Manufacturing Magazine for the Fited 3D printed scoliosis brace. The scoliosis brace is being developed by Fited and manufactured by Extol for mass customization.
Extol is pleased to announce that we have received a patent for our revolutionary nanoSTAKE plastic staking technology. This is Extol’s second patent for a staking technology that will change the manufacturing industry. NanoSTAKE was developed to.
Extol has launched a new Digital Development Center™ (DDC) to provide parts and engineering support to help customers develop high-value applications for additive manufacturing using HP Multi Jet Fusion technology.
Two components are used to focus the infrared energy in an InfraStake module, the reflector and the concentrator. The reflector is positioned behind the infrared lamp and directs the energy downward. The concentrator collects the energy and redirects it at the plastic boss, focusing it.
Extol is pleased to announce that CEMAS has been appointed as the sole distributor of Extol’s InfraStake product in Europe and South America. InfraStake is a patented infrared (IR) staking process that uses focused IR energy as the heat source. Through this distributor arrangement, European and South American machine builders and plastic parts manufacturers will have access to local sales and support for the InfraStake technology.
